Treatment of Chronic Idiopathic Cough (CIC) and Chronic Cough in Patients with Idiopathic Pulmonary Fibrosis (IPF) with PA101

Trial Profile

Treatment of Chronic Idiopathic Cough (CIC) and Chronic Cough in Patients with Idiopathic Pulmonary Fibrosis (IPF) with PA101

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Sep 2017

At a glance

  • Drugs Sodium cromoglicate (Primary)
  • Indications Idiopathic pulmonary fibrosis
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Patara Pharma
  • Most Recent Events

    • 21 Sep 2017 According to a Patara Pharma media release, data were published in The Lancet Respiratory Medicine.
    • 24 May 2017 Results presented at the 113th International Conference of the American Thoracic Society
    • 07 Sep 2016 Primary endpoint has been met. (cough frequency), as reported by a Patara Pharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top